Do you want to change careers? Are you absolutely sure?
From my own career change to the stories I hear from my clients and workshop students, often we think we want to change careers when the problem is our work environment instead. If you find yourself stuck, unsure what to do next, or t
Following billionaire investor Warren Buffett into stocks he owns has often been a profitable strategy over the past few decades. But reversing the orderbuying a stock before Buffett buys itcan potentially be even more rewarding.
Quiz: How Well Do You Really Know Warren Buffett?
With that in mind, we went prospecting for companies that Berkshire Hathaway (BRK-B, $137), Buffetts holding....More>>>
Doug Hughes focuses on lesser-known, small cap regional banks; the editor of Bank Newsletter looks for banks that operate in attractive regional markets, often ones that would be attractive acquisition targets.
AvidBank Holdings (AVBH) has the fastest growth of any bank out there and yet is still one of the safest with almost no bad loans, and a great, great market area in Palo Alto,....More>>>
Los Angeles, CA, based Investment company Capital World Investors buys Simon Property Group Inc, Enbridge Inc, Costco Wholesale Corp, Charter Communications Inc, Wells Fargo, Altria Group Inc, Aetna Inc, Barrick Gold Corp, Sherwin-Williams Co, BlackRock Inc, sells Merck Inc, Spectra Energy Corp, Exxon Mobil Corp, Praxair Inc, Chevron Corp during the 3-months ended 2017-03-31, according to the most....More>>>
Achaogen (NASDAQ:AKAO) is a clinical-stage biotechnology company specializing in creating antibiotics to treat MDR (multidrug resistant) bacteria. Its lead candidate, plazomicin, recently was recommended for approval for cUTI (complicated urinary tract infections) on May 2 by an FDA advisory com
Depomed (NASDAQ:DEPO) dropped 0% during mid-day trading on Tuesday . The stock traded as low as $6.58 and last traded at $6.69. Approximately 3,739,419 shares traded hands during mid-day trading, an increase of 190% from the average daily volume of 1,287,687 shares. The stock had previously clo
Analysts expect that Achaogen (NASDAQ:AKAO) will report earnings of ($0.96) per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for Achaogen’s earnings. The lowest EPS estimate is ($1.08) and the highest is ($0.83). Achaogen po
Shares of Achaogen (AKAO) rose by up to 90% just a few months after my December article suggesting readers buy the secondary offering. The stock has completed the round trip back down and then some, currently in the red by 20% from where we first started.